Work

TGFβI gene promoter methylation as a biomarker of resistance to anti-HER2 therapies in HER2-positive breast cancer

Year: 2024
Type: dissertation
Study design: Observational Study
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: closed
OpenAlex ID: W7126286361
Cites:
Cited by:
Related to: